1 |
nonalcoholic steatohepatitis
(7999 times)
|
Gastroenterology (2260 times)
|
NAFLD (3485 times) HCC (719 times) MCD (407 times)
|
1989 Nonalcoholic steatohepatitis: a study of 49 patients.
|
2 |
nonalcoholic fatty liver disease
(6 times)
|
Physiology (2 times)
|
4-HNE (1 time) CA (1 time) CD74 (1 time)
|
2014 Physiologically realistic and validated mathematical liver model reveals [corrected] hepatobiliary transfer rates for Gd-EOB-DTPA using human DCE-MRI data.
|
3 |
NAFLD and steatohepatitis
(5 times)
|
Food (2 times)
|
NAFLD (5 times) HYF (1 time) INR (1 time)
|
2004 Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.
|
4 |
National Audit of Seizure management in Hospitals
(5 times)
|
Neurology (2 times)
|
EDs (2 times) CAPS (1 time) SUS (1 time)
|
2015 National Audit of Seizure management in Hospitals (NASH): results of the national audit of adult epilepsy in the UK.
|
5 |
nonalcoholic hepatic steatosis and steatohepatitis
(4 times)
|
Pathology (2 times)
|
NAFLD (3 times) ER (1 time) FABP3 (1 time)
|
2008 Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
|
6 |
NAFLD can progress to steatohepatitis
(3 times)
|
Endocrine System Diseases (1 time)
|
NAFLD (3 times) HFD (1 time) MVs (1 time)
|
2017 Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.
|
7 |
NASH group
(3 times)
|
Microbiology (1 time)
|
BDM-X (2 times) HCC (2 times) FPG (1 time)
|
2011 Impact of glucose tolerance on the severity of non-alcoholic steatohepatitis.
|
8 |
non-acute subdural haematomas
(3 times)
|
Neurosurgical Procedures (1 time)
|
GOS (1 time)
|
2019 Factors influencing the results of surgical therapy of non-acute subdural haematomas.
|
9 |
non-alcoholic fatty liver disease and steatohepatitis
(3 times)
|
Gastroenterology (1 time)
|
APRI (1 time) FIB-4 (1 time) HFD (1 time)
|
2017 Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
|
10 |
nonalcoholic hepatitis
(3 times)
|
Neoplasms (1 time)
|
ER (1 time) HCC (1 time) HFD (1 time)
|
2016 Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health.
|
11 |
nucleic acid spot hybridization
(3 times)
|
Biochemistry (1 time)
|
PCR (2 times) BBTD (1 time) BBTV (1 time)
|
2009 Detection of Huanglongbing (citrus greening) disease by nucleic acid spot hybridization.
|
12 |
NAFLD progresses from benign steatosis to steatohepatitis
(2 times)
|
Biochemistry (1 time)
|
NAFLD (2 times) ASOs (1 time) FSP27 (1 time)
|
2017 Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate.
|
13 |
nearest accessible specialist hospital
(2 times)
|
Pulmonary Medicine (1 time)
|
NSCLC (2 times)
|
2014 Survival of Australian lung cancer patients and the impact of distance from and attendance at a thoracic specialist centre: a data linkage study.
|
14 |
non-alcoholic hepatosteatosis
(2 times)
|
Fibrosis (1 time)
|
ATP (1 time) HSCs (1 time) MAFLD (1 time)
|
2016 Activation of hepatic stellate cell in Pten null liver injury model.
|
15 |
non-alcoholic liver disease
(2 times)
|
Medicine (1 time)
|
AI (1 time) ALD (1 time) HBV (1 time)
|
2006 [Non-alcoholic liver disease (NASH)].
|
16 |
North Atlantic subtropical high
(2 times)
|
|
ISV (1 time) LLJ (1 time) SE US (1 time)
|
2018 Investigating the causes of increased 20th-century fall precipitation over the southeastern United States.
|
17 |
encompasses a spectrum from simple steatosis to steatohepatitis
(1 time)
|
Medicine (1 time)
|
DEGs (1 time) IPA (1 time) NAFLD (1 time)
|
2017 Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.
|
18 |
inflammation and steatohepatisis
(1 time)
|
Science (1 time)
|
NAFLD (1 time)
|
2010 The traditional Japanese formula keishibukuryogan reduces liver injury and inflammation in patients with nonalcoholic fatty liver disease.
|
19 |
NAFLD advancing to steatohepatitis
(1 time)
|
|
EVs (1 time) NAFLD (1 time)
|
2021 Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact.
|
20 |
NAFLD and its more-advanced form, steatohepatitis
(1 time)
|
Gastroenterology (1 time)
|
CTRL (1 time) D-NASH (1 time) FAO (1 time)
|
2022 Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD.
|
21 |
NAFLD and nonalcoholic hepatic steatohepatitis
(1 time)
|
Endocrinology (1 time)
|
NAFLD (1 time)
|
2022 Low levels of osteocalcin, but not CTX or P1NP, are associated with nonalcoholic hepatic steatosis and steatohepatitis.
|
22 |
NAFLD includes fatty liver alone or steatohepatitis
(1 time)
|
Anatomy (1 time)
|
NAFD (1 time)
|
2002 The clinicopathologic spectrum and management of nonalcoholic fatty liver disease.
|
23 |
NAFLD increases the risk of disease progression to steatohepatitis
(1 time)
|
Endocrinology (1 time)
|
DPP-4 (1 time) GLP-1RAs (1 time) NAFLD (1 time)
|
2020 Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease.
|
24 |
NAFLD ranges from simple fatty liver to steatohepatitis
(1 time)
|
Pharmacology (1 time)
|
HCC (1 time) NAFLD (1 time)
|
2005 The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
|
25 |
NAFLD with inflammatory features
(1 time)
|
Food (1 time)
|
BPF (1 time) CAF (1 time) IL-6 (1 time)
|
2018 Bergamot Polyphenols Boost Therapeutic Effects of the Diet on Non-Alcoholic Steatohepatitis (NASH) Induced by "Junk Food": Evidence for Anti-Inflammatory Activity.
|
26 |
NAFLD, and its more severe form with steatohepatitis
(1 time)
|
Endocrinology (1 time)
|
IR (1 time)
|
2014 High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
|
27 |
NAFLD, but can progress in some patients to advanced steatohepatitis
(1 time)
|
Gastroenterology (1 time)
|
BIA (1 time) CVD (1 time) MS (1 time)
|
2016 Patients with ultrasound diagnosis of hepatic steatosis are at high metabolic risk.
|
28 |
NAFLD, steatosis and steatohepatitis
(1 time)
|
Biochemistry (1 time)
|
NAFLD (1 time)
|
2010 Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?
|
29 |
NAFLD; lowest levels were observed in those with severe steatosis
(1 time)
|
Diabetes Mellitus (1 time)
|
CLA (1 time)
|
2019 Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link?
|
30 |
namely steatohepatitis
(1 time)
|
Gastroenterology (1 time)
|
NAFLD (1 time)
|
2012 Nonalcoholic fatty liver disease in Asia: a story of growth.
|
31 |
NASH and advanced fibrosis
(1 time)
|
Endocrinology (1 time)
|
AUCs (1 time) NAFLD (1 time) T2DM (1 time)
|
2019 Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes.
|
32 |
NASH patients
(1 time)
|
Gastrointestinal Diseases (1 time)
|
LP (1 time) MTTs (1 time) NAFLD (1 time)
|
2014 CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
|
33 |
NASH-HCC
(1 time)
|
Transplantation (1 time)
|
HCC (1 time) LT (1 time)
|
2018 Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma.
|
34 |
National Alliance for Safe Housing
(1 time)
|
Spouse Abuse (1 time)
|
---
|
2021 Identifying and Responding to the Complex Needs of Domestic Violence Housing Practitioners at the Onset of the COVID-19 Pandemic.
|
35 |
nations and ranges in severity from steatosis to steatohepatitis
(1 time)
|
Chemistry (1 time)
|
NAFLD (1 time) Nrf2 (1 time) ROS (1 time)
|
2019 Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction.
|
36 |
natural, accidental, suicidal, or homicidal
(1 time)
|
Health Services (1 time)
|
HCP (1 time)
|
2016 Improving the support of the suddenly bereaved.
|
37 |
necroinflammatory steatohepatitis
(1 time)
|
Gastroenterology (1 time)
|
CAD (1 time) miRNAs (1 time) NAFLD (1 time)
|
2016 Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease.
|
38 |
non-alcoholic fatty liver disease progression towards steatohepatitis
(1 time)
|
Antioxidants (1 time)
|
Glrx (1 time)
|
2022 Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis.
|
39 |
non-alcoholic steatohepatitis and cirrhosis
(1 time)
|
Immune System Diseases (1 time)
|
HCC (1 time) NAFL (1 time) NAFLD (1 time)
|
2021 Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns.
|
40 |
non-Ashkenazi
(1 time)
|
Allergy and Immunology (1 time)
|
AChR (1 time) ASH (1 time) MG (1 time)
|
2017 Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel.
|
41 |
non-invasive identification of steatohepatitis
(1 time)
|
Gastroenterology (1 time)
|
ION (1 time) LS (1 time) NPV (1 time)
|
2017 Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study.
|
42 |
non-invasive methods to detect steatohepatitis
(1 time)
|
Natural Science Disciplines (1 time)
|
AUROC (1 time) GE (1 time) MR (1 time)
|
2016 Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease.
|
43 |
Non-linear Attentional Saturation Hypothesis
(1 time)
|
Nervous System Diseases (1 time)
|
fMRI (1 time)
|
2018 Network Dynamics of Attention During a Naturalistic Behavioral Paradigm.
|
44 |
non-NASH
(1 time)
|
General Surgery (1 time)
|
BMI (1 time) HCV (1 time)
|
2018 Clinical Characteristics and Outcome of Morbidly Obese Bariatric Patients with Concurrent Hepatitis C Viral Infection.
|
45 |
non-steatohepatitis
(1 time)
|
Medicine (1 time)
|
NAFLD (1 time)
|
2020 Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD.
|
46 |
nonalcoholic fatty liver diseases and more advanced steatohepatitis
(1 time)
|
Cell Biology (1 time)
|
DKO (1 time) PRDX4 (1 time) SOD1 (1 time)
|
2018 Double Knockout of Peroxiredoxin 4 (Prdx4) and Superoxide Dismutase 1 (Sod1) in Mice Results in Severe Liver Failure.
|
47 |
nonalcoholic fatty liver hepatitis or steatohepatitis
(1 time)
|
Digestive System Surgical Procedures (1 time)
|
MAFLD (1 time) NAFL (1 time) NAFLD (1 time)
|
2021 Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD).
|
48 |
Norwegian summer-autumn spawning herring
(1 time)
|
Science (1 time)
|
NSAH (1 time) NSSH (1 time)
|
2017 Oogenesis and reproductive investment of Atlantic herring are functions of not only present but long-ago environmental influences as well.
|
49 |
number of affected relatives, age, smoking, and hypertension
(1 time)
|
Brain (1 time)
|
IAs (1 time)
|
2022 Number of Affected Relatives, Age, Smoking, and Hypertension Prediction Score for Intracranial Aneurysms in Persons With a Family History for Subarachnoid Hemorrhage.
|
50 |
Nutrition and Activity Self-History
(1 time)
|
Obesity (1 time)
|
ReCAP (1 time) WIC (1 time)
|
2013 Innovative tools help counselors discuss childhood obesity with parents.
|
51 |
only a small proportion of these patients develop steatohepatitis
(1 time)
|
Gastroenterology (1 time)
|
Hh (1 time)
|
2012 Mechanisms of disease progression in NASH: new paradigms.
|
52 |
Questionnaire-nonalcoholic steatohepatitis
(1 time)
|
Gastroenterology (1 time)
|
NAFLD (1 time) PROs (1 time)
|
2021 Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.
|